Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia.
Brian D AdkinsA B BarlowA JackS J SchultenoverM M DesoukiA C CooganVivian Lee WeissPublished in: Cytopathology : official journal of the British Society for Clinical Cytology (2018)
The evaluation of dysplasia can be challenging on Pap tests from transgender patients on androgen therapy. The cohort evaluated had higher rates of unsatisfactory and abnormal Pap tests. Pathologists should be familiar with the distinctive cytomorphological changes in the Pap tests from patients on androgen therapy to evaluate them appropriately.